U.S. Dialysis Services Market Size & Share 2026-2035

U.S. Dialysis Services Market Size

The U.S. dialysis services market was estimated at USD 36 billion in 2025. The market is expected to grow from USD 37.7 billion in 2026 to USD 51.5 billion in 2035, at a CAGR of 3.5% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market is driven by numerous factors such as increasing incidence of diabetes leading to kidney disorders, expansion of dialysis centers, rising number of end stage renal diseases (ESRD) patients coupled with favourable reimbursement scenario available for dialysis treatment in the country, among other factors.

Increasing awareness and education on kidney health, growing aging population and adoption of digital health and remote monitoring solutions are expected to fuel the industry's growth. DaVita Inc., Fresenius Medical Care, U.S. Renal Care, Inc., Satellite Healthcare, and Dialysis Clinic, Inc. are among the leading players operating in the market. These players mainly focus on service availability across the country, geographic expansion, strong research and development, and partnership with local healthcare facilities, among other factors.

The market has increased from USD 33.1 billion in 2022 and reached USD 34.7 billion in 2024, with a historic growth rate of 2.5%. The favorable reimbursement landscape, particularly through government programs like Medicare and Medicaid in the U.S., significantly influences the adoption of dialysis treatment. For instance, according to data published by the National Institutes of Health (NIH) in 2023, 70.5% of U.S. patients who received dialysis for end-stage kidney disease (ESKD) had Medicare as their primary payer. Medicare and Medicaid coverage for dialysis procedures alleviates the financial burden on patients, making it more affordable for them to receive ongoing treatment. This encourages patients to adhere to prescribed dialysis regimens and reduces the risk of treatment discontinuation due to cost barriers.

Additionally, increased R&D investment is continuously fostering innovation in dialysis technology and treatment modalities, leading to the development of advanced dialysis treatment options. These innovations aim to enhance treatment efficacy, patient comfort, and overall outcomes in dialysis therapy. By investing in R&D, companies introduce novel solutions that address unmet clinical needs and improve the delivery of dialysis services in the U.S. This focus on innovation drives product differentiation, expands market opportunities, and fosters competitiveness, thus driving further market expansion.

Dialysis services refer to a range of medical procedures and treatments designed to support individuals with impaired kidney function or end-stage renal disease (ESRD). These services encompass various modalities, including hemodialysis and peritoneal dialysis, which aim to remove waste products, excess fluids, and toxins from the blood when the kidneys are unable to perform these functions adequately.

U.S. Dialysis Services Market Trends

The prevalence of end-stage renal disease (ESRD) is on the rise in the U.S., primarily due to factors such as an aging population, a higher incidence of chronic conditions like diabetes and hypertension, and improved survival rates for patients with kidney diseases.

• For instance, according to NIH data, in 2022, around 808,000 people in the U.S. were suffering from end-stage renal disease, and this number is expected to increase in the near future. As the number of individuals diagnosed with ESRD increases, so does the demand for dialysis services to manage their condition.
•  Moreover, the aging population is more susceptible to chronic kidney disease (CKD) and ESRD. As people age, their kidneys may naturally decline in function, leading to the development of kidney diseases. Additionally, older adults are more likely to have comorbidities such as diabetes and hypertension, which further increase their risk of developing ESRD. The demographic shift toward an older population contributes to the growing demand for dialysis services.
•  Furthermore, efforts to improve access to healthcare, including preventive services, early detection, and treatment for kidney diseases, contribute to the diagnosis of ESRD at earlier stages. Early intervention and timely initiation of dialysis therapy help manage the progression of kidney failure and improve patient outcomes. Increased access to healthcare services ensures that ESRD patients receive the necessary dialysis treatments, thereby fueling the growth of the dialysis services market.

U.S. Dialysis Services Market Analysis

Based on type, the market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment accounted for a majority share of 87.3% in 2025. Shortage of donor kidneys increasing need for dialysis is anticipated to fuel the segmental growth. The segment is expected to reach USD 45.7 billion by 2035, growing at a CAGR of 3.7% during the forecast period.

• Hemodialysis is the most commonly used modality for dialysis treatment in the U.S. It involves filtering blood through an artificial kidney (dialyzer) to remove waste products and excess fluid. The widespread adoption of hemodialysis is attributed to its effectiveness in managing end-stage renal disease (ESRD) and its availability in various healthcare settings, including dialysis centers, hospitals, and even home-based settings.
• Additionally, the U.S. healthcare system has a well-established infrastructure to support hemodialysis services. Dialysis centers equipped with hemodialysis equipment, trained staff, and medical resources are widely accessible across the country. This infrastructure facilitates the delivery of hemodialysis treatments to a large patient population, contributing to its dominant market share.
• The peritoneal dialysis segment was valued at USD 4.6 billion in 2025. Instead of using a machine to remove waste and fluid from the blood, peritoneal dialysis uses the lining of the belly, called the peritoneum, to act as a natural filter.
• Further, an abdominal catheter is used to put a cleaning solution (dialysate) into the abdomen, which absorbs waste and fluid through the processes of diffusion and osmosis, after which the waste and solution are drained out and replaced.
• Moreover, strict attention to hand hygiene, patient education/training, and long-term care of the catheter is needed to avoid infection.

Based on service, the U.S. dialysis services market is segmented into acute dialysis and chronic dialysis. The chronic dialysis segment generated the highest revenue of USD 28.9 billion in 2025.

• Patients with ESRD typically require long-term or lifelong dialysis treatment to manage their condition effectively. Chronic dialysis involves regular, scheduled sessions, usually multiple times per week, to remove waste products and excess fluids from the bloodstream. This ongoing treatment regimen ensures that patients receive the necessary renal support to maintain their health and well-being.
• Additionally, chronic dialysis services are delivered in specialized healthcare settings staffed by multidisciplinary teams of nephrologists, nurses, technicians, and other healthcare professionals with expertise in renal care. These teams provide comprehensive clinical management, monitoring, and supportive care to patients undergoing chronic dialysis, ensuring optimal treatment outcomes and patient well-being, and contributing to the widespread adoption of these services.
• The acute dialysis segment was valued at USD 7.2 billion in 2025. Acute dialysis is provided to patients experiencing sudden, severe kidney failure due to conditions such as trauma, infection, dehydration, or medication toxicity.
• In addition, both hemodialysis and peritoneal dialysis can be used to provide treatment depending on the criticality of the situation, how stable the patient is, and where the patient is being treated (e.g., inpatient vs. outpatient).
• Further, acute dialysis patients are majorly treated in a hospital or during an intensive care unit admission, and it is critical to prevent serious complications while renal function improves.

Based on end use, the U.S. dialysis services market is segmented into in-center dialysis and home dialysis. The in-center dialysis segment accounted for the leading market share of 81.8% in 2025.

• Dialysis centers are equipped with advanced dialysis machines and medical professionals specializing in renal care. This access to specialized equipment and staff enhances the quality of care provided to patients, leading to better treatment outcomes and providing reassurance for patients and their families.
• Additionally, in-center dialysis facilities offer a structured and controlled environment for patients during their treatment sessions. The clinical setting provides a sense of security and familiarity for patients, allowing them to feel comfortable and relaxed during their dialysis treatments.
• Furthermore, in-center dialysis is typically covered by insurance plans, including Medicare and private insurance. This coverage makes it an accessible option for many patients, eliminating financial barriers to treatment and increasing its preference among individuals with end-stage renal disease (ESRD).
• The home dialysis segment was valued at USD 6.6 billion in 2025. Home dialysis allows eligible patients to perform treatments independently or with caregiver assistance, offering greater schedule flexibility and improved quality of life.
• Further, home therapies allow more frequent or gentler dialysis treatments to provide better symptom management and reduce traveling for treatment.

South Atlantic Dialysis Services Market

The South Atlantic dialysis services market accounted for a majority share of 22.7% in 2025 and is anticipated to show notable growth over the forecast period.

• The South Atlantic dialysis services market was valued at USD 7.6 billion and USD 7.7 billion in 2022 and 2023, respectively. In 2025 the market size was valued at USD 8.2 billion from USD 7.9 billion in 2024.
• The high market share in the South Atlantic zone can be attributed to several factors, including the presence of key market players, a robust research and development infrastructure, significant government funding for dialysis research, and a high adoption rate of advanced technologies in the healthcare sector.
• Additionally, high healthcare expenditure and insurance coverage contribute to the accessibility and affordability of dialysis services and treatments for patients in the South Atlantic zone.

Northeast Dialysis Services Market

Northeast accounted for a significant share of the U.S. market and was valued at USD 5.8 billion in 2025.

• Northeast zone is among the leading market for dialysis services in the country, with a strong healthcare system and high standards of care.
• The increasing demand for dialysis in several states of the Northeast zone can be attributed to factors such as improved awareness, the need for effective disease management, the convenience of home dialysis, aging population, government support, and technological advancements.
• Additionally, the increasing prevalence of ESRD and the growing demand for personalized medicine in Northeast region contribute to the expansion of dialysis services.

Mountain States Dialysis Services Market

The Mountain States dialysis services market accounted for a substantial share of the market and was valued at USD 2.2 billion in 2025.

• Contributing factors include the growing incidence of diabetes, hypertension, obesity, and aging populations. These conditions gradually impair kidney function over time, leading to CKD.
•  Moreover, efforts to promote kidney health in the region are improving access to screening and early detection, thereby mitigating the burden of renal disorders on individuals and society and significantly contributing to market growth.

U.S. Dialysis Services Market Share

The U.S. market is highly concentrated, dominated primarily by DaVita Inc. and Fresenius Medical Care, which together account for the majority of operational dialysis centers nationwide. DaVita and Fresenius both hold approximately the same number of facilities throughout the country, around 2,600 to 2,800 dialysis centers, and roughly similar market share in the market. Both companies have set the highest standards for operational and technological excellence within this industry and may help establish future leaders in dialysis services.

In addition, besides these two providers, there are a few medium-sized and mission-based organizations that play an important role in the competitive landscape. Together, U.S. Renal Care, Dialysis Clinic Inc. (DCI), and Satellite Healthcare serve considerable patient populations and compete using community-based models, non-profit objectives, and patient-centered care approaches.

Furthermore, competitive pressures are intensifying as providers expand home‑dialysis programs, integrate digital monitoring systems, and pursue innovative care models. Providers are now working to provide more patient convenience and flexibility in treatments, as well as utilizing technology-enabled services in order to remain competitive. As the landscape continues to shift due to both the rise in the number of ESRD patients and the increase of patients taking home dialysis, providers are being driven toward innovation, differentiation, and responsible scaling to meet the ongoing demand for these services over time.

U.S. Dialysis Services Market Companies

A few of the prominent players operating in the U.S. dialysis services industry include:

• Centers for Dialysis Care
• DaVita Inc.
• Dialysis Clinic, Inc.
• Fresenius Medical Care
• Innovative Renal Care
• Rogosin Institute
• Sanderling Renal Services
• Satellite Healthcare
• U.S. Renal Care, Inc.
• Vantive

• DaVita Inc.

DaVita focuses on expanding value‑based care models, strengthening home‑dialysis programs, enhancing digital patient‑management tools, and partnering with health systems to improve coordinated kidney‑care delivery nationwide.

• Fresenius Medical Care

Fresenius emphasizes integrated care solutions, investing in advanced dialysis technologies, expanding home‑therapy capabilities, optimizing global supply chains, and enhancing clinical efficiency to deliver consistent, high‑quality renal‑care services.

U.S. Dialysis Services Industry News:

• In December 2024, Baxter International Inc. announced that they had signed a definitive agreement with Carlyle under which they have acquired Baxter's Kidney Care segment for USD 3.8 billion. The newly formed company is known as Vantive. Through this development, Vantive aims to achieve operational sales growth of 4% to 5% annually.
• In April 2023, DaVita Inc. and Medtronic plc collaboratively announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions. This strategic move helped the company focus on and serve patients with kidney disease.
• In May 2022, Sanderling Renal Services, Inc., announced a strategic partnership with Pharos Capital Group, LLC, to enhance their dialysis and renal care services in remote locations across the U.S. This partnership helped the company enhance its home dialysis operations and improve its business operations, thus strengthening its market position.

The U.S. dialysis services market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Hemodialysis 
• Peritoneal dialysis

Market, By Service

• Acute dialysis
• Chronic dialysis

Market, By End Use

• In-center dialysis
• Home dialysis

The above information is provided for the following zones and states:

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• Northeast
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• Pacific Central
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming